[Mycobacterium tuberculosis, Aspergillus fumigatus and secondary mixed flora in cavernostomy caverns].
D001228:Aspergillosis / Q000382:microbiology*; D002701:Chloramphenicol / Q000494:pharmacology; D004322:Drainage; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009355:Neomycin / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D013902:Radiography, Thoracic; D013210:Staphylococcus / Q000302:isolation & purification; D013307:Streptomycin / Q000494:pharmacology; D013530:Surgical Wound Infection / Q000382:microbiology*; D014397:Tuberculosis, Pulmonary / Q000382:microbiology*
D010406:Penicillins; D002701:Chloramphenicol; D009355:Neomycin; D010118:Oxytetracycline; D013307:Streptomycin
Mycobacterium tuberculosis, Aspergillus fumigatus und sekundäre Mischflora in Kavenostomiehöhlen.